Quantcast

Latest Tenofovir Stories

2014-05-21 12:16:10

IQWiG Added benefit based on fewer side effects / no data for adolescents and pretreated adults who do not require integrase inhibitors Dolutegravir has been approved since January 2014 in combination with other antiretroviral drugs for the treatment of human immunodeficiency virus (HIV) infected adults and adolescents above 12 years of age. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality...

Researcher Finds Soy Sauce Molecule May Unlock Drug Therapy For HIV Patients
2014-05-05 03:45:36

Jeff Sossamon / Roger Meissen, University of Missouri Compounds can be 70 times more potent than Tenofovir, a first-line HIV regimen For HIV patients being treated with anti-AIDS medications, resistance to drug therapy regimens is commonplace. Often, patients develop resistance to first-line drug therapies, such as Tenofovir, and are forced to adopt more potent medications. Virologists at the University of Missouri now are testing the next generation of medications that stop HIV from...

2014-04-18 23:04:22

Markets Research Reports.biz added deep and professional market research reports on "HIV Therapeutics Market To 2019" Industry Analysis and Overview. Visit: http://www.marketresearchreports.biz/analysis/193009 (PRWEB) April 18, 2014 The leading business intelligence provider GBI Research has released its latest research report, entitled “HIV Therapeutics Market to 2019 – Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress...

2014-03-06 08:30:17

Additional drug-drug interaction data for faldaprevir combined with commonly prescribed HIV medications also presented at CROI 2014 INGELHEIM, Germany and RIDGEFIELD, Conn., March 6, 2014 /PRNewswire/ -- Today Boehringer Ingelheim announced results from STARTVerso(®)4 in patients with HCV/HIV co-infection. Hepatitis C viral cure 12 weeks after the conclusion of treatment (SVR12) was achieved by 72% of all patients in the trial. Patients were enrolled in either 120mg or 240mg...

2014-01-31 00:21:48

PITTSBURGH and MUMBAI, India, Jan. 31, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its India-based subsidiary Mylan Pharmaceuticals Private Limited has been named Gilead Sciences, Inc.'s (Nasdaq: GILD) exclusive branded medicines business partner for India. Under the agreement, Mylan will market and distribute in India Gilead's: -- HIV therapies Viread(® )(tenofovir disoproxil fumarate), Truvada(®) (emtricitabine/tenofovir disoproxil fumarate) and the...

New Technology Combining Contraception, HIV And Herpes Simplex Virus-2 Prevention
2013-11-12 12:19:08

CONRAD Multipurpose prevention technologies featured at AAPS Annual Meeting and International Conference on Family Planning CONRAD Head of drug delivery, Meredith Clark, PhD, today presented preclinical data on a new intravaginal ring that provides contraception as well as HIV-1 and HSV-2 prevention at the 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in San Antonio, Texas. This multipurpose prevention technology (MPT) can remain in the...

HIV Prevention For Women Through New Intravaginal Ring
2013-09-28 05:09:09

April Flowers for redOrbit.com - Your Universe Online The HIV/AIDS epidemic often has a woman's face because the proportion of women infected with HIV has been on the rise for a decade. For example, in sub-Saharan Africa, women constitute 60 percent of people living with disease. Preventative drugs are available, but they are often ineffective, especially in light of financial and cultural barriers in developing nations. The answer, according to a new study published in the Proceedings...

Tenofovir Helps Prevent Contraction Of HIV
2013-06-13 13:20:00

Brett Smith for redOrbit.com - Your Universe Online New research from the Centers for Disease Control and Prevention suggests that a daily pill can prevent the contraction of HIV for intravenous drug users. The four-year study, which was published in The Lancet, boosts the argument of those advocating a preventative strategy called “¯pre-exposure prophylaxis, or PrEP. "This is a significant step forward for HIV prevention," Jonathan Mermin, a CDC spokesman who was not...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.